2023 Fiscal Year Final Research Report
Development of educational materials for medical professionals and patients in cancer genomic medicine.
| Project/Area Number |
20K18862
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 58010:Medical management and medical sociology-related
|
|---|
| Research Institution | Tokai University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2020-04-01 – 2024-03-31
|
| Keywords | がんゲノム医療 / がん遺伝子パネル検査 / 臨床腫瘍医 / がん治療認定医 / 医師アンケート調査 |
|---|
| Outline of Final Research Achievements |
In 2019, cancer gene panel testing became covered by insurance in Japan, but it is limited to 240 certified facilities. Given this situation, a survey was conducted to assess cancer treatment doctors' understanding of cancer genome medicine. The results showed that doctors at core and affiliated cancer genome hospitals had higher knowledge and usage experience compared to other doctors. The most common reason for not using the testing was "poor patient PS," with non-certified hospitals citing "inability to perform tests at their facility," "difficulty accessing testing facilities," and "lack of understanding" more frequently. At the time of the survey, cancer genome medicine was not widely adopted, highlighting the urgent need for more facilities, simplified procedures, network building, and personnel training.
|
| Free Research Field |
ゲノム医療
|
| Academic Significance and Societal Importance of the Research Achievements |
がんゲノム医療中核拠点病院や拠点病院とそれ以外の病院において、知識やがんゲノム医療利用状況に差があることが判明した。アンケート実施時において、がんゲノム医療の普及は進んでおらず、施設増加、手順の簡便化、ネットワーク構築、人材育成が急務と考えられた。特に、がんゲノム病院以外に勤務する医師ががんゲノム医療を利用しやすい体制を構築することが重要と考えられた。 本研究成果は、がんゲノム医療を適切に患者に届ける体制の一助となり、わが国においてがんゲノム医療の均てん化を図ることを促進するものと確信する。
|
